One-Shot immune reset: early trial tests CAR-T therapy for debilitating muscle disease
Disease control
Ongoing
This early-phase study is testing an investigational one-time cell therapy called CABA-201 in adults with generalized myasthenia gravis (gMG), a rare autoimmune disease that causes severe muscle weakness. The therapy aims to reset the immune system by removing the harmful B cells…
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC